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ABSTRACT 
The vestibulo-cerebellum calibrates the output of the inherently leaky brainstem neural 
velocity-to-position integrator to provide stable gaze holding. In healthy humans small-
amplitude centrifugal nystagmus is present at extreme gaze-angles, with a non-linear 
relationship between eye-drift velocity and eye eccentricity. In cerebellar degeneration this 
calibration is impaired, resulting in pathological gaze-evoked nystagmus (GEN). For 
cerebellar dysfunction, increased eye drift may be present at any gaze angle (reflecting pure 
scaling of eye drift found in controls) or restricted to far-lateral gaze (reflecting changes in 
shape of the non-linear relationship) and resulting eyed-drift patterns could be related to 
specific disorders. We recorded horizontal eye positions in 21 patients with cerebellar 
neurodegeneration (gaze-angle=±40deg) and clinically confirmed GEN. Eye-drift velocity, 
linearity and symmetry of drift were determined. MR-images were assessed for cerebellar 
atrophy. In our patients, the relation between eye-drift velocity and gaze eccentricity was non-
linear, yielding (compared to controls) significant GEN at gaze-eccentricities ≥20deg. Pure 
scaling was most frequently observed (n=10/18), followed by pure shape-changing (n=4/18) 
and a mixed pattern (n=4/18). Pure shape-changing patients were significantly (p=0.001) 
younger at disease-onset compared to pure scaling patients. Atrophy centered around the 
superior/dorsal vermis, flocculus/paraflocculus and dentate nucleus and did not correlate with 
the specific drift behaviors observed. Eye drift in cerebellar degeneration varies in magnitude, 
however, it retains its non-linear properties. With different drift patterns being linked to age at 
disease-onset, we propose that the gaze-holding pattern (scaling vs. shape-changing) may 
discriminate early- from late-onset cerebellar degeneration. Whether this allows a distinction 
among specific cerebellar disorders remains to be determined. 
 
  
INTRODUCTION 
 
Gaze-evoked nystagmus (GEN) is defined as a sustained centrifugal nystagmus [1] 
reflecting the brain’s response when eccentric gaze cannot be maintained and as a result the 
eyes drift back towards straight-ahead position [2, 3]. Horizontal gaze holding is provided by 
a brainstem horizontal neural velocity-to-position integrator [4, 5] located in the nucleus 
prepositus hypoglossi and the medial vestibular nucleus [3, 6]. Robinson proposed that the 
neural velocity-to-position integrator is inherently “leaky” and as a result requires cerebellar 
input to calibrate its output precisely in proportion to eye position [5]. Impaired gaze holding 
secondary to such “leaky” integration has been demonstrated in humans with acute [7, 8] and 
chronic [9-12] cerebellar disease and in primates after flocculectomy [13] or (hemi-
)cerebellectomy [14-16]. Centripetal eye-drift therefore is considered an essential clinical sign 
of a deficient brainstem neural velocity-to-position integrator or its cerebellar modulatory 
structures.  
At extreme angles of eccentric gaze, most healthy human subjects show a small-
amplitude horizontal centripetal eye drift, termed end-point nystagmus (EPN) [17, 18]. Gaze 
shifts to moderate horizontal eccentricities evoke only very weak centripetal eye drift in 
healthy subjects, as cerebellar control sufficiently compensates for the inherent leakiness of 
the brainstem gaze-holding network [4, 5, 13, 15]. We recently assessed horizontal gaze 
holding (range=±40deg) and quantified EPN in healthy human subjects, demonstrating over-
proportional increases in eye drift for gaze angles >20deg [19]. We hypothesized that the gaze 
holding system is optimized to behave linearly within a given range, but loses this behavior at 
larger gaze angles, resulting in a non-linear behavior even in healthy human subjects.  
In view of the non-linear relationship between eye-drift velocity and horizontal eye 
position and the physiological leakiness of gaze holding at extreme gaze-angles, we predict 
profound non-linear eye drift at eccentric gaze in patients with insufficient cerebellar control 
of the brainstem neural integrator. Different mechanisms (see also Figure 1) may explain 
increased eye drift: It may reflect 1) a pure scaling effect of eye drift, i.e. drift velocity 
increases by a given factor independently from the gaze angle, 2) that gaze becomes deficient 
only beyond a certain gaze-angle, reflecting a change in shape of the position-velocity curve 
rather than pure scaling, 3) a combination of mechanisms one and two. Possibly these 
mechanisms reflect a continuum of conditions, with scaling representing more advanced 
cerebellar disease with gaze-holding being impaired at small gaze-angles also or are “disease-
specific”. 
 
/* Figure 1 about here */ 
  
MATERIAL AND METHODS 
Subjects  
Twenty-one patients (63.0±13.3y, average±1 standard deviation [SD]) with various 
adult-onset neurodegenerative cerebellar disorders participated (Table 1). All of them 
displayed typical ocular motor signs of cerebellar disease including GEN, which was a 
prerequisite for inclusion. Written informed consent of all participants was obtained after a 
full explanation of the experimental procedure. The protocol was approved by the local ethics 
committee and was in accordance with the ethical standards laid down in the 2013 
Declaration of Helsinki for research involving human subjects.  
For comparison, gaze-holding data from 20 healthy human subjects (41±11y old) 
previously described by[19] was used. This control group was intended to represent optimal 
gaze holding properties and was, therefore, not age-matched.  
 A neuro-otological examination was performed in all participants. MRI-images 
previously obtained for clinical purposes were reviewed and the degree of cerebellar atrophy 
was rated by an experienced neuro-radiologist (BS) that was unaware of the clinical 
presentation of the patients.  
 
/* Table 1 about here */ 
 
Experimental setting 
All recordings were obtained on a chair mounted on a two (Tönnies D561, Freiburg, 
Germany) or three (prototype, Acutronic, Jona, Switzerland) servo-controlled motor-driven 
axes turntable system. Visual stimuli were generated by LEDs at eye level. The head was 
stabilized in upright position using a head-and-chin rest (Tönnies) or a thermoplastic mask 
(Acutronic). Horizontal eye movements were recorded in darkness at 220Hz with a head-
mounted video-oculography device (“EyeSeeCam”) [20, 21]. During recordings, one eye was 
covered with a lens filter, preventing vision but allowing video recording of the eye by the 
infrared camera. 
 
Experimental procedure 
 Participants were asked to look at a briefly flashing (50ms every 2s) LED without 
moving the head. The LED was positioned in the range of horizontal gaze eccentricity from -
40deg to +40deg. Each subject was tested in two subsequent runs, changing the order of 
presentation of the requested gaze eccentricities and for the right and left eye viewing 
separately. The LED always started straight-ahead and slowly displaced (0.5deg/s, i.e. by 
1deg at every flash) in one direction (random order) up to the maximum eccentricity before 
changing direction and completing the full cycle (up to 40deg of eccentricity into the direction 
of the viewing eye and up to 20deg of eccentricity into the opposite direction as the target gets 
covered by the nose at higher eccentricities). Both eyes were recorded simultaneously. A 
similar “slow-moving dot” paradigm had been used for data acquisition of 20 healthy human 
subjects,[19] with the only difference that no eye was covered and that the flashing LED 
covered the whole range of 80deg tested (±40deg) in each trial. Compared to the classic 
approach of quantifying gaze-holding deficits by use of saccades to certain, selected angles of 
gaze-eccentricity, the slow-moving dot paradigm has the advantage of much higher spatial 
resolution (1deg of horizontal gaze eccentricity), potentially allowing the identification of 
more subtle changes in gaze-holding deficits and superior fitting of mathematical models. In 
order to assess the impact of the selected paradigm on measured gaze-holding deficits, we 
also obtained the classic “saccade-based” paradigm in 13/21 patients (#3-6, 12-15, 17-21). In 
this paradigm desired gaze position was reached by a saccade from straight-ahead position. 
GEN was recorded at selected angles of eccentricity (-30deg to +30deg, steps=5deg, random 
order) indicated by a stationary flashing red dot (50ms every 2s for 6s). 
 Data analysis 
 Data analysis was done using interactive programs written in MATLAB (The 
Mathworks, Natick, MA). Velocity traces were obtained as the derivative of horizontal eye 
position traces. Saccades and blinks were removed interactively (see [19] for a detailed 
description). The resulting data points were assigned to one of 17 non-overlapping bins (bin-
width=5deg), covering together ±40deg of gaze eccentricity. Additionally, each participant’s 
instantaneous eye velocity was smoothed as a function of eye eccentricity using weighted 
linear least-squares robust regression (smooth.m, “rloess” algorithm, MATLAB) and 
interpolated at every 0.1deg [19]. Values from all dependent variables were evaluated for 
normality using Lillierfors test. Whenever normality was not confirmed, median and median 
absolute deviation (MAD) were used as descriptive statistic parameters instead of the mean 
and SD. Bonferroni correction was applied when multiple comparisons were made. 
 
Mathematical modeling 
 The instantaneous eye velocity of each subject from both groups was independently 
fitted with the following functions: 
1cE*mV +=          Eq.1 
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In both Eq.1 and Eq.2, V is the instantaneous eye velocity recorded while E is the 
corresponding instantaneous eye position. The linear slope m, the coefficients k1 and k2 and 
the offsets c1 and c2 were optimized with a least-square algorithm. Eq.1 specifies a linear 
dependency of the eye drift velocity on eye position. Eq. 2 is a modified version of the tangent 
function proposed previously [19]. Changes in k1 only cause changes in the shape of the 
tangent function, while changes in k2 lead to scaling up the velocity, preserving the shape.   
  
RESULTS 
Clinical and brain MRI findings 
Details of the clinical neurological examination can be found in Table 1. Ocular motor 
abnormalities (besides GEN) included downbeat-nystagmus (n=13), rebound-nystagmus 
(n=9) and saccadic smooth-pursuit (n=18). MRI demonstrated cerebellar atrophy in 19/20 
patients (see Table 2 for details). Within the vermis, lobules IV-VI (n=17/20), VIIa (n=14/20) 
and VIIb (n=10/20) were affected most frequently (see Fig. 2AB for an example), while 
lobules VIII-X were usually spared. The flocculus/paraflocculus was atrophic in 10/20 
patients (Fig. 2CD). Degenerative changes within the dentate nucleus were observed in 10/20 
patients (Fig. 2EF). Atrophy within the cerebellar hemispheres was most often found in the 
anterior parts (n=13/20). 
 
/* Figure 2 and table 2 about here */ 
 
Gaze holding – peak values, asymmetry and drift patterns 
In Figure 3 raw eye-position and eye-velocity data is shown for a healthy subject and a 
patient, illustrating differences in GEN. To emphasize the gaze-dependent eye drift, we 
plotted eye-drift velocity as a function of gaze eccentricity (‘Position-Velocity (PV) plots’). 
Three patients with different eye-drift behavior are shown in Figure 4A-C. In Figure 4D the 
gaze-holding properties in patients and controls are compared. For the following analysis, raw 
instantaneous velocity values were used. 
 
/* Figures 3 and 4 about here */ 
 
Eye-drift velocity values were assigned to 5deg-bins and median drift velocity of each 
subject in each bin was calculated. Eye-drift velocity was significantly higher in patients for 
bins centered at ≥20deg (p<0.001, nonparametric Mann-Whitney-Wilcoxon test) (Table 3). 
The median asymmetry ratio of the eye-drift velocities within each pair of 
corresponding bins from left and right gaze was 1.41 [0.23; 1MAD], not being significantly 
(p>0.05, nonparametric Mann-Whitney-Wilcoxon test) different from the healthy controls’ 
median (1.56 [0.34]). The median of the absolute differences between the corresponding bins 
in the patients group ranged between 0.66deg/s [0.31deg/s] at 40deg and 0.11deg/s 
[0.08deg/s] at 5deg. 
 
/* Table 3 about here */ 
 
The two parameters of the tangent function allowed differentiating between distinct 
changes of the drift behavior. While the first parameter (k1) characterized the increase of eye 
drift at large gaze angles compared to small ones (i.e., refers to its shaping), the second 
parameter (k2) described the global amount of eye-drift velocity over the range of gaze angles 
studied (i.e., refers to its scaling). For the patients, the median r2 of the tangent function (0.80 
[0.10]) was significantly (p=0.007) higher than the value obtained with a linear function (0.75 
[0.14]), matching what previously was shown in healthy subjects [19]. We split the k1-k2 
parameter-space in four subspaces, using the median+1MAD of k1 and k2 estimated from the 
controls as thresholds (Figure 5A). Four patients showed a significant increase restricted to k1; 
in 10 patients only k2 was significantly larger. Four patients exceed the threshold for both 
parameters. 
 
/* Figure 5 about here */ 
 
Correlation between clinical parameters and drift patterns observed  
With age at symptom onset ranging between 30 and 79 years, two clusters could be 
identified: an early-onset group (n=8; range=30-43y; average±1SD=35.6±5.0y) and a late-
onset group (n=13; range=57-79y; average±1SD=65.5±5.5y). Amongst those patients with 
early disease-onset, disease duration varied considerably (13.6±8.4y; range 4-26y). We, 
however, did not observe different drift patterns for early-onset patients as a function of 
disease duration. Overall, six out of those eight patients showed significant GEN, with the 
drift pattern being shape-changing in four. Pooling the two clusters, disease duration was 
significantly longer in the pure shape-changing group compared to the pure scaling group 
(13.8±9.3y vs. 6.0±4.1y, p=0.046, two-sample t-test). Both mean age at recording (50.3±7.6y 
vs. 68.1±13.3y, p=0.028) and at symptom onset (36.5±7.0y vs. 62.1±11.2y, p=0.001) in the 
pure shape-changing group was significantly lower than in the pure scaling group.  
Other clinical parameters such as frequency of downbeat nystagmus (ranging between 
50 and 75% in patients with GEN) and dysarthria (ranging between 25 and 100%) showed 
either only a trend towards significant differences (p=0.093 for rates of dysarthria in pure 
shape-changing vs. pure scaling patients, Fisher’s exact test) or were not significantly 
different (p>0.05). 
Possibly, a global increase of eye-drift velocity (i.e. pure scaling) as noted in our 
scaling patients could also be related to a physiological decrease in gaze-holding control with 
increasing age. However, a correlation analysis (regress.m, built-in Matlab function) between 
the amount of eye drift and age in our healthy control subjects did not confirm such a pattern 
[R2=0.00, p=0.98, slope=0.0005 (95% confidence interval: -0.386 to 0.386)].  
 
Slow-moving dot paradigm vs. classic saccade-based paradigm 
The 12 bins corresponding to gaze eccentricities of ≤30deg were used to compare drift 
velocities obtained with the slow-moving dot and the saccade-based paradigm (see Fig. 5BC 
for two representative patients). Eye-drift velocity recorded with the saccade-based paradigm 
was significantly higher for bins centered at 15deg (p<0.001, nonparametric Wilcoxon 
signed-rank test) or larger. Pooling all bins and subjects, the mean ratio was 0.48±0.19 (Table 
2). We fitted the traces of the 13 patients who underwent both paradigms with Eq.2 (results 
see legend of Fig. 5). By calculating the variation of the parameter values within each subject, 
we found it significantly different from 0 for k2 (+62% [9%], p<0.001), but not for k1 (-23% 
[44%]), indicating that changes in the drift pattern between the two paradigms were driven by 
changes in scale only. Of the 18 patients characterized by an abnormal value of at least one 
parameter using the slow-moving dot paradigm, 12 were tested with the saccade-based 
paradigm and five showed a change in the classification: Three patients previously 
categorized as pure shape-changing (#6, 15 and 20) were now classified as scaling&shape-
changing. One patient (#5) switched from pure scaling to combined scaling&shape-changing 
in the saccade-based paradigm, one patient (#13) switched from combined scaling&shape-
changing to pure scaling in the saccade-based paradigm.  
DISCUSSION 
Gaze holding is provided by the inherently ‘leaky’ brainstem neuronal velocity-to-
position integrator, whose performance is optimized by the vestibulo-cerebellum [5, 22]. 
Gaze-evoked nystagmus (GEN) is considered an essential clinical sign of a deficient 
brainstem neural velocity-to-position integrator or its cerebellar modulatory structures. Here 
we discuss the results of 21 patients with neurodegenerative cerebellar disease that presented 
with impaired gaze holding to the Department of Neurology of the University Hospital 
Zurich, Switzerland. This study was driven by the hypothesis that patients with cerebellar 
disease will show profound non-linear eye drift at eccentric gaze and that a more thorough 
observation of the pattern of eye drift behavior may allow a distinction between different 
patient populations - probably linked to the underlying disease. Compared to controls, eye-
drift velocity was significantly higher for gaze eccentricities as small as ±20deg, being 
consistent with previous reports describing GEN at eccentricities of ±15deg in patients with 
cerebellar dysfunction [23]. We found the increase of centripetal eye-drift velocity as a 
function of gaze eccentricity to be markedly non-linear, reproducing the eye-drift behavior we 
observed at extreme lateral gaze-angles in healthy human subjects [19]. Fitting confirmed that 
it could best be approached by a tangent function.  
We propose for the first time a link between the pattern of eye-drift behavior and age 
at disease-onset in patients with neurodegenerative cerebellar disease. Specifically, patients 
presenting with pure shape-changing of eye-drift behavior had significantly (p=0.001) earlier 
disease-onset compared to patients with pure scaling of eye-drift behavior. This global 
increase in eye-drift velocity in elderly patients with cerebellar degeneration cannot be 
explained by physiological age of cerebellar structures, as in our healthy control subjects we 
did not observe any increase in eye-drift velocity with age.  
We believe that our detailed characterization of gaze holding is also of relevance for 
the clinical assessment of patients with suspected gaze-holding deficits, since it implies that 
testing a single gaze angle (as usually performed at the bedside) might be insufficient. 
Specifically, the current clinical approach bears the risk of under-estimating or over-
estimating impairments in gaze holding, depending on the gaze angle chosen and the drift 
behavior (scaling, shape-changing). We therefore propose more thorough testing including 
different gaze angles to determine the characteristics of GEN at the bedside.  
 
Different patterns of drift behavior in cerebellar degeneration 
Here we describe a non-linear relationship between eye-drift velocity and gaze 
eccentricity in patients with cerebellar neurodegeneration. As a result of this non-linearity a 
distinction between different gaze-dependent eye-drift behaviors can be made. From the 18 
patients with significant GEN, scaling of the healthy subjects behavior was observed in 14 
and changes in the shape of the gaze behavior in eight. While in four of these eight patients, 
changes in shape were accompanied by changes in scale, eye drift pattern in the remaining 
four only changed in shape, i.e. abnormal eye drift velocity was limited to the most eccentric 
gaze positions. Considering the two observed behaviors, it can be hypothesized that pure 
shape-changes reflect earlier stages of cerebellar degeneration, with gaze holding remaining 
sufficient over a broad range of (small and medium-sized) gaze angles, while later gaze 
holding becomes impaired globally as reflected by changes in scale. However, a ‘mild’ 
disease-severity rating (Table 1) and shorter disease duration was found more frequently in 
the pure scaling group (70%) compared to the pure shape-changing group (50%), which 
argues against scaling reflecting more advanced/severe cerebellar dysfunction. Furthermore, 
disease duration was significantly (p=0.046) shorter in the pure scale-changing group 
compared to the pure shape-changing group. We therefore consider it unlikely that the drift 
pattern is related to the stage of disease. Noteworthy, both mean age at symptom-onset and at 
recording time in the pure shape-changing group were significantly (p<0.05) lower than in the 
pure scaling group. This raises the question whether the drift pattern (defining whether gaze-
holding failure is global or restricted to far-lateral gaze) could be linked rather to the patient’s 
age than to the disease duration. While we do see support for this hypothesis, we would like to 
emphasize, that we found the same pure shape-changing GEN behavior in two affected 
brothers aged 35 and 31 years at symptom-onset (#6 and #15) with presumably autosomal-
dominant cerebellar ataxia. This and the fact that the average age of symptom-onset varies 
considerably for different neurodegenerative cerebellar disorders, we hypothesize that the 
various drift behaviors could be a consequence of distinct genetically defined cerebellar 
syndromes becoming symptomatic at different ages. This hypothesis, however, is limited by 
the fact that genetic testing was lacking in most of our patients and that the diagnosis 
remained descriptive. 
 
Only scale of GEN is affected by the specific paradigm applied 
While traditionally paradigms using saccades to reach static eccentric targets were 
applied to quantify GEN, the target used here was slowly displacing and flashing. Whereas 
this resulted in much higher spatial resolution and more robust measurements of the position-
velocity (PV)-plot, it also made GEN more prone to adaptation, since subjects’ gaze remained 
at (large) angles of eccentricity over a prolonged period of time. Thereby the amount of GEN 
is likely underestimated by our paradigm. This explains also why the three pure shape-
changing patients from the slow-moving dot paradigm were found to have additional (minor) 
scaling in the saccade-based paradigm. A subject-by-subject comparison between our 
paradigm and the classic approach revealed that eye-drift velocity at bins centered at ±15deg 
or larger was significantly (p<0.001) lower, reaching in median 48% of the values obtained 
with the classical saccade-based paradigm. However, our fit revealed that these differences 
were related to changes in scale only. The resulting PV-plots, indeed, resemble in shape those 
obtainable from the classic saccade-based paradigm. Therefore we can conclude that the 
pattern of eye-drift velocity is not paradigm-specific but reflects a general behavior of 
cerebellar dysfunction. Hence, as the main feature assigning patients to one of our groups was 
the presence/absence of a change in shape with respect to the normal PV-plot, the distinction 
between the two different observed behaviors holds. It must be taken into account, however, 
that using one or the other paradigm results in observing two different values of drift velocity. 
Accordingly, using the classical saccade-based paradigm, one should expect to observe 
patients with a pure scaling effect, forming one group, and patients showing a change in shape 
paired with a minor scaling effect, forming the second group. Therefore, in the saccade-based 
paradigm, the distinction between the three different groups identified in the slow-moving dot 
paradigm may be less clear. While the addition of minor scaling to pure shape-changing in 
three patients can be explained by less GEN adaptation in the saccade-based paradigm, the 
addition (#5) or loss (#13) of shape-changing in addition to scaling observed in two patients 
when using the saccade-based paradigm needs to be addressed further. In these two patients, 
such shifts in the shape-changing parameter are most likely paradigm-related and could 
potentially be explained by higher uncertainty levels and smaller sample size (only few non-
continuous gaze angles measured) in the saccade-based paradigm, affecting the mathematical 
modeling used to determine scaling and shape-changing parameters.  
From the clinical perspective, we advocate the use of the slow-moving dot paradigm in 
the evaluation of patients with vestibulo-cerebellar disease instead of the saccade-based 
paradigm, as with this quantitative approach a much more detailed characterization of gaze-
holding deficits can be achieved. While overall eye-drift velocity values were lower in the 
slow-moving dot paradigm, this did not result in a lower rate of detection of gaze-holding 
impairments in the patients. Higher resolution of the slow-moving dot paradigm therefore will 
likely improve the identification of more subtle gaze-holding deficits, however, needs further 
confirmation in future studies in order to become the new “gold standard” in the evaluation of 
gaze-holding deficits in cerebellar loss of function.  
 
Distribution of cerebellar atrophy in patients with GEN 
Based on the MRI-assessment, we propose a characteristic pattern of distribution of 
cerebellar atrophy in patients with impaired gaze holding (n=18/21) due to neurodegenerative 
cerebellar disease. Almost invariably (n=15/18) we noted involvement of the superior and 
dorsal vermis (especially lobules IV-VIIb). Additional areas of atrophy in these 15 patients 
with vermal atrophy included the anterior lobe of the cerebellar hemispheres (n=10/15), the 
flocculus/paraflocculus (n=7/15) and the dentate nucleus (n=9/15). The caudal parts of the 
vermis (uvula, nodulus) were usually spared. We did not identify distinct patterns of 
cerebellar atrophy related to the eye-drift behavior observed. 
In the literature there is conflicting information about the cerebellar gaze-holding 
network. With floccular/parafloccular involvement in half of the patients, our data is in 
agreement with results from lesion studies in non-human primates identifying the flocculus as 
key structure for gaze holding [13]. In accordance with our observation, the dentate nucleus 
has previously been identified as part of the cerebellar gaze-holding network [24]. Whether 
the superior and dorsal vermal lobules contribute to gaze holding is not clear. The lobules of 
the superior vermis (lobules I to V) are known to integrate vestibular and proprioceptive input 
[25] and are likely important for postural stability [26], while lobules VI and VII contribute to 
smooth pursuit and saccades [27]. Noteworthy, partial midline/paramedian cerebellectomy 
including vermal lobules IV-IX, but sparing the dentate nucleus and the 
flocculus/paraflocculus did not result in GEN in two cats [16]. These studies therefore suggest 
that the superior and dorsal vermal lobules do not belong to the cerebellar gaze-holding 
network and rather propose that this network relies on other cerebellar structures, such as the 
dentate nucleus [24] or the flocculus/paraflocculus [13].  
Noteworthy, the quality and resolution of MRI varied among individual participants, 
which may have limited the MRI-ratings. Furthermore, the amount of cerebellar atrophy in 
patients presenting with cerebellar dysfunction strongly depends on the underlying disease. In 
two brothers with suspected ADCA both MRI findings and GEN patterns were very similar, 
suggesting that a given underlying genotype may indeed be reflected in a characteristic 
phenotype of cerebellar gaze-holding impairment.  
 
In conclusion, we confirm that in patients with neurodegenerative disease the increase 
of GEN as a function of gaze eccentricity is markedly non-linear. Gaze-angles as small as 
20deg resulted in significantly increased amplitudes of GEN compared to healthy human 
subjects, reflecting the insufficiently compensated leakiness of the neuronal velocity-to-
position integrator. We emphasize that the observed age-dependent differences in the drift 
behavior (pure shape-changing in the young vs. pure scaling in the elderly) are likely disease-
specific with underlying disorders becoming symptomatic at distinct ages. This potentially 
allows the discrimination between early- and late-onset cerebellar neurodegeneration based on 
eye-drift patterns, but requires examination of gaze holding at different angles of gaze 
eccentricity. Whether this will allow the distinction of different cerebellar neurodegenerative 
disorders based on gaze-holding deficits or not, will be subject to future studies in patients 
with genetically confirmed, cerebellar disorders.  
 
  
FIGURES 
Figure 1:  
Illustration of simulated data showing two possible predicted eye drift behaviors in relation to 
horizontal eye position in patients with neurodegenerative cerebellar disease (grey lines) and 
comparison with a healthy control subject (black solid line). Increases in eye drift velocity in 
the patients are indicated by black arrows. In the first patient (grey dashed line) eye velocity 
values over the entire range of gaze angles are multiplied by a given value, reflecting „pure 
scaling“ behavior. In the second patient (grey solid line), eye drift velocity values remain 
within normal up to approximately 20-25° of gaze eccentricity and only for more extreme 
gaze angles, significant increases in eye drift velocity can be observed, reflecting a „pure 
shape-changing“ behavior of eye drift. In addition, patients may show patterns between pure 
shape-changing and pure scaling, referred to as scaling&shape-changing behavior. 
  
Figure 2:  
Atrophic changes in different cerebellar areas – exemplary illustration in single patients (left 
column) and comparison with normal findings (right column). Panel A: severe atrophy of the 
superior and dorsal cerebellar vermis with relative sparing of the caudal vermis (patient #15, 
sagittal T2-weighted MR-sequence). Panel B: sagittal T2-weighted MR-image of the 
cerebellar vermis in a healthy human control subject with segregation of the different vermal 
lobuli.[28] Panel C: Axial FIESTA (fast imaging employing steady state acquisition) image 
demonstrating moderate atrophy of the flocculus (indicated by the white dashed arrows) in 
patient #12. Panel D: axial FIESTA image in a subject with normal volume of the flocculus 
(solid white arrow) for comparison. Panel E: Axial diffusion-weighted (DWI) imaging 
showing reduced volume and loss of hypointensity of the dentate nucleus (dashed white 
arrows) in patient #6. Panel F: axial DWI illustrating normal volume and signal intensity of 
the dentate nucleus (solid white arrows) in a healthy human control. Courtesy of MR-images: 
Department of Neuroradiology, University Hospital Zurich, Switzerland (panels A, C, F) and 
MRI Institute, Zurich, Switzerland (panels B, D, E). 
 
Figure 3:  
Raw data recorded in a single trial from a control subject (panels A and C) and a typical 
patient (# 17; panels B and D). Note that in the patient a single trial was shorter due to the 
smaller range of gaze covered (60deg vs. 80deg, patients vs. controls) as one eye was covered. 
In panels A and B eye position is plotted as function of time. Positive angles correspond to 
right gaze eccentricities as seen by the subject. Inset 1: at extreme eccentricities the 
centrifugal beating nystagmus is clearly visible in the control subject as well. Inset 2: At the 
same eccentricity of gaze as in inset 1, GEN in this patient is much stronger than in the 
controls. In panels C and D eye velocity is plotted against time.  The eye velocity begins to 
decrease from its baseline before the onset of the nystagmus, showing the growing centrifugal 
drift. Compared to the control subject (panel C), eye drift velocity in the patient (panel D) is 
considerably larger, indicating more GEN. 
 
Figure 4:  
PV-plots providing eye drift velocity for all gaze eccentricities tested illustrate the different 
drift behaviors in individual patients (panels A-C) and pooled for all patients and controls 
(panel D). Both single raw data points (in grey) and the fit of the tangent function (black solid 
line) are shown for each patient. To set the drift behavior of the patients in relation to that of 
the healthy controls, the mean fit in the healthy controls is provided both as originally 
obtained (black dashed line) and scaled-up to match the eye drift velocity of the patient (black 
dotted line). For patients that showed an increase of eye drift velocity for all angles of gaze 
eccentricity, the scaled-up fit from the controls will match the patient’s fit well (panel A). 
Likewise, patients that presented with increased eye drift velocity only at larger angles of gaze 
eccentricity, the mean fit from the controls will match the patient’s drift behavior within a 
certain range of drift angles without scaling, but for larger gaze angles, changes in shape are 
occurring (panel B). A combination of scaling and shaping was observed in some subjects as 
well (panel C). In panel D, the mean of the patients’ position-velocity (PV) plots (black solid 
trace) ±1SD (light-gray area) is presented for each gaze eccentricity tested. The dark gray 
shaded area refers to the healthy controls’ mean trace ±1SD. The eye drift velocity behaved 
similarly in the patient group and the control group, growing with gaze eccentricity and 
showing a pronounced non-linearity at large gaze eccentricities, with eye drift velocity in the 
patients being clearly higher. Average (±1SD) peak eye drift velocity was 5.9deg/sec 
(±4.5deg/sec) for the patients (obtained at 32.2±5.3deg of eccentricity). 
 
Figure 5:  
Panel A: segregation of the drift behavior based on the distribution of model parameters k1 
and k2 in the 21 patients (referred to by triangles). Thereby each patient’s drift pattern is 
classified as either pure scaling, pure shape-changing, combined scaling&shape-changing or 
within normal limits. Cutoff values (indicated by the solid black lines) for significantly 
increased k1 and k2 values are defined as values above the mean values (grey dashed lines) 
plus 1SD of the healthy controls.  The median values for the parameters using the tangent fit 
were k1=1.69 [0.55], k2=3.94 [2.39] and c2=-0.16 [0.46] for patients and k1=1.54 [0.28], 
k2=1.17 [0.62], c2=-0.02 [0.29] for healthy subjects. A significant difference was observed for 
k2 (p=0.002, nonparametric Mann-Whitney-Wilcoxon test), but not for k1 and c2. 
Panels B and C: comparison of the PV-plot obtained with the slow-moving dot paradigm 
(gray dotted line) and obtained with the saccade-based paradigm (black solid line) in a typical 
subject with a shaping-only drift behavior (panel B) and a subject with a pure scaling drift 
behavior (panel C). Since overall drift was stronger for the classic saccade-based paradigm, 
eye drift velocity for the slow-moving dot paradigm was scaled up accordingly to allow better 
comparison (black dashed line). The grey dotted line indicates the non-scaled eye drift 
velocity from the slow-moving dot paradigm. Fitting the traces of all 13 patients who 
underwent both paradigms with Eq.2 resulted in the following median parameters for the 
saccade-based paradigm: k1=2.10 [0.71], k2=6.07 [2.70] and c2=0.05 [0.43]. The r2 was 0.96 
[0.03]. The median of the parameters estimated on data acquired in the same range of gaze 
eccentricities from the slow-moving dot paradigm in same 13 subjects were k1=1.99 [0.47], 
k2=3.33 [1.75] and c2=-0.01 [0.32] (r2=0.95 [0.04]).  
 
  
TABLES 
Table 1: demographic and clinical data of all patients with diffuse, chronic vestibulo-cerebellar degeneration 
Patient * Age 
at 
onset 
Diagnosis DBN GEN / RBN GA / 
LA 
DA Saccadic 
SPEM 
Clinical 
disease 
rating † 
Peak eye drift 
vel [deg/s] 
(angle [deg)] 
Eye drift pattern Genetic testing 
#1, m, 56 30 Probable ADCA - ++(l>r) / ++ ++ / + ++ ++ moderate 4.2 (33.5) shaping neg.: SCA1-3,6-8 
#2, f, 60 35 Probable EA II + + / - - / - - - mild 1.5 (38.7) normal neg.: SCA6, CACNA1A 
#3, m, 75 68 SAOA + ++ / ++ + / + - ++ mild 8.1 (-38.3) shaping & scaling NA 
#4, m, 71 64 Probable ADCA +++ ++ / - ++ / + + ++ moderate 7.2 (-33.4) scaling NA 
#5, m, 39 35 Probable ADCA +++ ++ / - (+) / - - ++ mild 7.1 (-39.0) scaling NA 
#6, m, 47 ~43 Probable ADCA + ++ / - ++ / ++ + + moderate 2.5 (-29.0) shaping neg.: FXTAS, see also brother (#15) 
#7, m, 85 79 SAOA (+) ++(r>l) / - + / - - ++ mild 14.5 (35.1) scaling NA 
#8, m, 67 61 SAOA (+) ++ / ++ ++ / + ++ ++ moderate 16.6 (24.2) scaling NA 
#9, f, 46 31 ADCA - ++(l>r) / ++ ++ / ++ + ++ moderate 6.1 (-33.6) shaping & scaling CACNA1A (R1668W mutation) 
#10, m, 67 64 SAOA - ++ / - ++ / - ++ +++ moderate 8.0 (39.1) scaling NA 
#11, m, 71 64 FXTAS - +(r>l) / - ++ / + - ++ mild 0.9 (19.8) normal FMR1 (CGG: 85 repeats) 
#12, f, 73 71 SAOA - ++  / + ++ / ++ - ++ moderate 5.9 (33.8) shaping & scaling NA 
#13, f, 68 ~65 SAOA + ++ / - - / - - ++ mild 7.3 (-28.9) shaping & scaling NA 
#14, m, 59 57 SAOA (+) + / + ++ / + + + mild 3.3 (38.1) scaling neg.: FRDA, SCA1-3,6-8,10,12,17 ‡ 
#15, m, 41 31 Probable ADCA + + / - + / + ++ + mild 2.3 (28.3) shaping neg.: SCA1-3,6,7,10,12,17, DRPLA, see #6 
#16, f, 86 71 SAOA - ++ / ++ + / + - NA mild 12.0 (33.7) scaling NA 
#17, f, 74 63 Probable ADCA + + / - ++ / - - ++ mild 3.5 (33.2) scaling NA 
#18, f, 67 64 SAOA - ++(l>r) / (+) ++ / + - + mild 9.5 (-28.8) scaling NA 
#19, f, 66 63 Superf. siderosis + + / - + / + - + mild 2.6 (-30.2) scaling NA 
#20, m, 57 42 CANVAS ++ +(r>l) / ++ ++ / + + - mild 0.7 (33.3) shaping NA 
#21, m, 48 38 Probable ADCA - + / - ++ / (+) + + mild 0.6 (-24.9) normal NA, see also brother (#1) 
 
* Includes the patient number, the sex (m=male, f=female) and the age (years). Four patients belonged to two families (brothers: #1 and #21; #6 and #15). 
† Rating based on clinical neurological examination for gait ataxia, limb ataxia, dysarthria and ocular motor abnormalities (only GEN). For each of these four categories, 0 
(finding absent), 1 (finding present and rated as mild), 2 (finding present and rated as moderate) or 3 (finding present and rated as severe) points were given and the mean value 
was determined. The overall clinical rating of cerebellar dysfunction was then either mild (mean value <1.5), moderate (mean value ≥ 1.5 and < 2.5) or severe (mean value ≥ 2.5). 
‡ Genetic testing of mitochondrial DNA showed two 9kbp deletions of unclear significance. Testing of nuclear genom not performed due to lack of coverage of costs. 
 
Rating for clinical findings: absent (-), mild (+), moderate (++), severe (+++) 
 
Abbreviations: ADCA = autosomal-dominant cerebellar ataxia; CANVAS = Cerebellar ataxia, neuropathy, vestibular areflexia syndrome; CH = cerebellar hemispheres; DA= 
dysarthria; DBN = downbeat nystagmus; FRDA = Friedreich Ataxia; FXTAS = fragile-X tremor ataxia syndrome; Fl = flocculus; GA = gait ataxia; GEN = gaze-evoked 
nystagmus; LA = limb ataxia; ME = mesencephalon; NA = not available; NeoCb = Neo-cerebellum; P = pons; RBN = rebound nystagmus; SAOA = sporadic adult-onset ataxia 
of unknown origin; V = vermis; VestCb = vestibulo-cerebellum 
  
Table 2: MRI findings – rating of atrophy [absent (-), mild (+), moderate (++), severe (+++)] 
   
FL PF 
Vermis* ND CH† Tons 
Patient 
[#, sex, age] 
Diagnosis MRI  
[y] 
Ling 
(I, II) 
LC 
(III) 
Cul 
(IV, V) 
Decl 
(VI) 
Fol 
(VIIa) 
Tub 
(VIIb) 
Pyr 
(VIII) 
Uv 
(IX) 
Nod 
(X) 
 Upper Central Lower   
#1, m, 56 Probable ADCA 2010 - - - ++ ++ +++ - - - - - - ++ - - - 
#2, f, 60 Probable EA II 2011 L:++ 
R:- + - - ++ ++ - - - - - - + + + - 
#3, m, 75 SAOA 2008 - - - - + + + + - - - + - - - - 
#4, m, 71 SAOA 2008 - - - - + + + - - - - +++ - - - - 
#5, m, 39 SAOA 2011 ++ ++ - - + + + - - - - +++ + - - - 
#6, m, 47 Probable ADCA 2010 - + +++ +++ +++ +++ +++ +++ - - - +++ ++ - - - 
#7, m, 85 SAOA 2007 ++ ++ - - + + - - - - - - - - - - 
#8, m, 67 SAOA 2009 + ++ - - + + + ++ - - - +++ - ++ - - 
#9, f, 46 ‡ ADCA 
(CACNA1A) 
1997                 
#10, m, 67 SAOA 2009 - - - - - - - - - - - - - - - - 
#11, m, 71 FXTAS 2009 - + - - - - - + - - - + + - - - 
#12, f, 73 SAOA 2013 + + - - - - - - - - - - - - - - 
#13, f, 68 SAOA 2012 + - 
++ 
+ - 
++ - - ++ ++ ++ ++ - - - + ++ ++ - - 
#14, m, 59 SAOA 2012 - - - + + + + - - - - + + - - - 
#15, m, 41 Probable 
ADCA 
2013 + + + +++ +++ +++ ++ ++ - - - ++ +++ + - - 
#16, f, 86 SAOA 2012 - - - - + ++ + - - - - - + - - - 
#17, f, 74 Probable ADCA 2013 - - - - + ++ + - - - - + + - - - 
#18, f, 67 SAOA 2013 - - - + ++ ++ + + - - - - - - - - 
#19, f, 66  Superficial 
siderosis 
2013 +++ ++
+ 
+++ 
§ 
+++ 
§ 
+++ 
§ 
+++ 
§ 
+++ 
§ 
+ 
§ 
+ + + - ++ - - + 
#20, m, 57 CANVAS 2011 - - - - + ++ + + - - - - ++ + + - 
#21, m, 48 Probable ADCA 2014 - - - ++ ++ ++ ++ + - - - - + - - - 
 
* Nomenclature according to consensus and (in brackets) Schmahmann and co-workers [28]. 
† Segregation of the cerebellar hemispheres in an upper, central and lower part, with the fissura prima separating the upper and central part and the fissura horizontalis between 
the central and lower part. 
‡ This MRI-scan could not be retrieved. The radiologist’s report stated “diffuse cerebellar atrophy being most pronounced in the cranial part of the vermis”.  
§ These parts of the vermis were completely replaced by cystic defects, most likely secondary to infarction. 
 
Abbreviations: CH=cerebellar hemispheres; Cul=culmen; Decl=declive; Fol=folium; FL=flocculus; LC= lobules centralis; Ling=lingula; ND=nucleus dentatus; Nod=nodulus; 
PF=paraflocculus; Pyr=pyramis; Tons=tonsils; Tub=tuber; Uv=uvula. 
Table 3: Eye drift velocity – comparison between patients and controls and between the slow-
moving dot paradigm and the saccade-based paradigm 
 
Patients (n=21) vs. controls (n=20): comparison of eye drift velocity (slow-moving dot paradigm 
only) [deg/s] 
Gaze angle [deg] 
(center of bin)* 
40† 35† 30† 25† 20† 15 10 5 0 
Patients 4.3 
[2.8] 
3.7 
[2.4] 
2.7 
[1.6] 
2.2 
[1.3] 
1.4 
[0.8] 
0.8 
[0.6] 
0.4 
[0.5] 
0.1[0.3] 0.1 [0.3] 
Healthy subjects 1.1 
[0.7] 
0.9 
[0.6] 
0.7 
[0.4] 
0.6 
[0.3] 
0.5 
[0.3] 
0.4 
[0.3] 
0.3 
[0.3] 
0.1 
[0.2] 
0.0 [0.1] 
Patients only: comparison of eye drift velocity between the two paradigms (n=13) [deg/s] 
Gaze angle [deg] 
(center of bin)* 
  30‡ 25‡ 20‡ 15‡ 10 5 0 
Slow moving    2.6 
[0.9] 
2.1 
[1.1] 
1.2 
[0.7] 
0.5 
[0.5] 
0.4 
[0.4] 
0.1 
[0.2] 
0.1 [0.3] 
Saccade-based   3.7 
[1.6] 
3.2 
[1.6] 
2.2 
[0.9] 
1.4 
[1.0] 
0.7 
[0.7] 
0.3 
[0.4] 
N/A 
 
* Values from corresponding bins on right and left gaze were pooled. 
† At these angles median eye drift velocity was significantly (p<0.001) larger in the patient group compared to 
the control group. 
‡ At these angles median eye drift velocity was significantly (p<0.001) larger for the saccade-based paradigm 
compared to the slow-moving dot paradigm. 
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